4-(((4-(2-Methoxyphenoxy)phenyl)sulfonamido)methyl)benzoic acid, 97%, 250mg

6-(4-methylpiperazin-1-yl)pyridazin-3-ol, 95.0%, 500mg

sec-butyl[(2E)-3-phenyl-2-propen-1-yl]amine hydrochloride, 95.0%, 5g

5-chloro-3-(4-methoxyphenyl)-1,2,4-thiadiazole, 95.0%, 2g

3-(AMINOMETHYL)-4-METHYLPHENOL, 95%, 100mg

cis-3,4-Difluoropyrrolidine hydrochloride, 95.0%, 5g

4-Bromo-2-(bromomethyl)-1-methoxybenzene, 95.0%, 25g

5-(6-Carboxynaphthalen-2-yl)isophthalic acid, 98%, 250mg

(S)-1-(3-Chlorophenyl)-2,2,2-trifluoroethan-1-amine hydrochloride, 95%, 1g

Isobutyric acid, >=99%, for synthesis, 1 L, glass packaging

[6-(4-Amino-phenyl)-4-trifluoromethyl-pyridin-2-yl]-dimethyl-amine, 95.0%, 1g

1,5-Diamino-4,8-dihydroxyanthraquinone>95.0%(HPLC)(N)25g

5-Chloro-1,3-dimethyl-1H-pyrazole-4-carboxylic acid, 97.0%, 1g